- Home
- Publications
- Publication Search
- Publication Details
Title
NK Cell-Based Immunotherapy for Hematological Malignancies
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 10, Pages 1702
Publisher
MDPI AG
Online
2019-10-17
DOI
10.3390/jcm8101702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia
- (2019) Alexander Hallner et al. BLOOD
- Immune Cell-Derived Extracellular Vesicles – Functions and Therapeutic Applications
- (2019) Rosanne E. Veerman et al. TRENDS IN MOLECULAR MEDICINE
- Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
- (2019) Lin Xiao et al. MOLECULAR THERAPY
- Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer–Based “Off-the-Shelf” Acute Myeloid Leukemia Immunotherapies
- (2019) Stephan Kloess et al. HUMAN GENE THERAPY
- Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
- (2019) Simona Sivori et al. Cellular & Molecular Immunology
- The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
- (2019) Stefan O. Ciurea et al. BONE MARROW TRANSPLANTATION
- Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering
- (2019) Olaf Oberschmidt et al. Human Gene Therapy Methods
- Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
- (2019) Laurent Gauthier et al. CELL
- Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
- (2019) Kristina Ellwanger et al. mAbs
- A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44
- (2019) Annika Niehrs et al. NATURE IMMUNOLOGY
- NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans
- (2019) Monica Parodi et al. Frontiers in Immunology
- The Natural Cytotoxicity Receptors in Health and Disease
- (2019) Alexander David Barrow et al. Frontiers in Immunology
- Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
- (2019) Tiziano Ingegnere et al. Frontiers in Immunology
- Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
- (2019) Daniela Pende et al. Frontiers in Immunology
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
- (2019) Silvia Pesce et al. Frontiers in Immunology
- Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
- (2019) Francesca Romana Mariotti et al. Frontiers in Immunology
- An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More
- (2019) Massimo Vitale et al. Frontiers in Immunology
- Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
- (2019) SoonHo Kweon et al. Frontiers in Immunology
- Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
- (2019) Kyle B. Lupo et al. Cancers
- True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity
- (2019) Luke Riggan et al. TRENDS IN IMMUNOLOGY
- NK Cell Plasticity in Cancer
- (2019) Sizhe Liu et al. Journal of Clinical Medicine
- Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
- (2019) C. Quintarelli et al. LEUKEMIA
- Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells
- (2019) Changjiang Guo et al. MOLECULAR IMMUNOLOGY
- Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation
- (2018) Sarah Cooley et al. BLOOD
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword
- (2018) Willemijn Hobo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
- (2018) May Daher et al. CURRENT OPINION IN IMMUNOLOGY
- Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide
- (2018) Avichai Shimoni et al. LEUKEMIA
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct human circulating NKp30+FcεRIγ+CD8+T cell population exhibiting high natural killer-like antitumor potential
- (2018) Margareta P. Correia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia
- (2018) Franco Locatelli et al. TRENDS IN IMMUNOLOGY
- Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells
- (2018) Iñigo Terrén et al. Frontiers in Immunology
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming
- (2018) Cristina Capuano et al. Frontiers in Immunology
- Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
- (2018) Silvia Gaggero et al. OncoImmunology
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
- (2018) Anthony Stein et al. DRUG SAFETY
- The IL-15–AKT–XBP1s signaling pathway contributes to effector functions and survival in human NK cells
- (2018) Yufeng Wang et al. NATURE IMMUNOLOGY
- Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
- (2018) Michelle L. Saetersmoen et al. Seminars in Immunopathology
- Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
- (2018) Xiu-Man Zhou et al. Frontiers in Immunology
- Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy
- (2017) Janet Ayello et al. EXPERIMENTAL HEMATOLOGY
- Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
- (2017) Delphine Rea et al. HAEMATOLOGICA
- The Broad Spectrum of Human Natural Killer Cell Diversity
- (2017) Aharon G. Freud et al. IMMUNITY
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?
- (2017) Catharina H. M. J. Van Elssen et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
- (2017) K H Chen et al. LEUKEMIA
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
- (2017) Laura Chiossone et al. SEMINARS IN IMMUNOLOGY
- Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia
- (2017) Josep-Maria Ribera Expert Review of Hematology
- CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
- (2017) E. Mejstríková et al. Blood Cancer Journal
- Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
- (2017) Delphine Rea et al. HAEMATOLOGICA
- Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells
- (2017) Lisa L. Liu et al. Cancer Immunology Research
- The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
- (2017) John P. Veluchamy et al. Frontiers in Immunology
- The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
- (2017) Sarah Parisi et al. Frontiers in Immunology
- Role of Distinct Natural Killer Cell Subsets in Anticancer Response
- (2017) Helena Stabile et al. Frontiers in Immunology
- A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
- (2017) Juliane Wagner et al. Frontiers in Immunology
- Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
- (2017) Anushruti Sarvaria et al. Frontiers in Immunology
- Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
- (2017) Cristina Capuano et al. OncoImmunology
- Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen–Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency
- (2016) Giuseppina Li Pira et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Exploitation of natural killer cells for the treatment of acute leukemia
- (2016) Rupert Handgretinger et al. BLOOD
- Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
- (2016) A. Curti et al. CLINICAL CANCER RESEARCH
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Roles of CD48 in regulating immunity and tolerance
- (2016) Shannon L. McArdel et al. CLINICAL IMMUNOLOGY
- A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
- (2016) Bai Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
- (2016) Annette Romanski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2016) Arend von Stackelberg et al. JOURNAL OF CLINICAL ONCOLOGY
- An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
- (2016) S P Koerner et al. LEUKEMIA
- Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
- (2016) M Ilander et al. LEUKEMIA
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
- (2016) Kevin H. Chen et al. Oncotarget
- IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation
- (2016) G. C. Sim et al. Cancer Immunology Research
- T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR- +/CD19+ lymphocytes
- (2015) I. Airoldi et al. BLOOD
- A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
- (2015) A. Rothe et al. BLOOD
- NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
- (2015) Garnet Suck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cell Adoptive Transfer Therapy
- (2015) Zachary B. Davis et al. CANCER JOURNAL
- A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
- (2015) D. M. Benson et al. CLINICAL CANCER RESEARCH
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
- (2015) Heinrich Schlums et al. IMMUNITY
- DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
- (2015) Katrin Töpfer et al. JOURNAL OF IMMUNOLOGY
- Human Cytokine-Induced Memory-Like Natural Killer Cells
- (2015) Melissa M. Berrien-Elliott et al. Journal of Innate Immunity
- CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
- (2015) F Cichocki et al. LEUKEMIA
- Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies
- (2015) Liping L. Sun et al. Science Translational Medicine
- Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
- (2015) Theofanis Floros et al. SEMINARS IN ONCOLOGY
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
- (2015) Monica Parodi et al. OncoImmunology
- Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions
- (2015) Claire Germain et al. OncoImmunology
- Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
- (2015) U. Koehl et al. OncoImmunology
- CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
- (2015) Jianfeng Han et al. Scientific Reports
- KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
- (2014) L. Oevermann et al. BLOOD
- CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
- (2014) M. K. Gleason et al. BLOOD
- HLA-haploidentical stem cell transplantation after removal of + T and B cells in children with nonmalignant disorders
- (2014) A. Bertaina et al. BLOOD
- Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia
- (2014) Peter Lang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
- (2014) E. Schlecker et al. CANCER RESEARCH
- Infusions of Allogeneic Natural Killer Cells as Cancer Therapy
- (2014) W. Leung CLINICAL CANCER RESEARCH
- Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation
- (2014) Monica Killig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells
- (2014) G. F. Torelli et al. HAEMATOLOGICA
- KIR/HLA Interactions Negatively Affect Rituximab- but Not GA101 (Obinutuzumab)-Induced Antibody-Dependent Cellular Cytotoxicity
- (2014) G. Terszowski et al. JOURNAL OF IMMUNOLOGY
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity
- (2013) K. S. Reiners et al. BLOOD
- Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin
- (2013) Shivani Srivastava et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: A different perspective of the host-pathogen interaction
- (2013) Aura Muntasell et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy
- (2013) Satiro Nakamura De Oliveira et al. HUMAN GENE THERAPY
- Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2
- (2013) Jonathan Sitrin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- Neuroblastoma-Derived TGF- 1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
- (2013) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models
- (2013) S. Herter et al. MOLECULAR CANCER THERAPEUTICS
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+T cells into innate-like effector cells with antitumor activity
- (2013) Hing C Wong et al. OncoImmunology
- A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
- (2012) N. Vey et al. BLOOD
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
- (2012) M Stern et al. BONE MARROW TRANSPLANTATION
- Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
- (2012) Christiane Sahm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
- (2012) J. Hilpert et al. JOURNAL OF IMMUNOLOGY
- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
- (2012) Gregory L. Moore et al. mAbs
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- New Approaches to Graft Engineering for Haploidentical Bone Marrow Transplantation
- (2012) Rupert Handgretinger SEMINARS IN ONCOLOGY
- Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
- (2012) Leo Luznik et al. SEMINARS IN ONCOLOGY
- KIR2DL4 (CD158d): An activation receptor for HLA-G
- (2012) Sumati Rajagopalan et al. Frontiers in Immunology
- Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism
- (2011) S. Veeramani et al. BLOOD
- Differentiation of human peripheral blood V 1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
- (2011) D. V. Correia et al. BLOOD
- Haploidentical hematopoietic transplantation: current status and future perspectives
- (2011) Y. Reisner et al. BLOOD
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- Use of NK cell activity in cure by transplant
- (2011) Wing Leung BRITISH JOURNAL OF HAEMATOLOGY
- Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor
- (2011) D V Tassev et al. CANCER GENE THERAPY
- IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
- (2011) Kai-ping Han et al. CYTOKINE
- Human NK receptors: From the molecules to the therapy of high risk leukemias
- (2011) Lorenzo Moretta et al. FEBS LETTERS
- Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia
- (2011) Régis T. Costello et al. IMMUNOLOGY
- Use of allogeneic NK cells for cancer immunotherapy
- (2011) Melissa A Geller et al. Immunotherapy
- NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
- (2011) Ruth Esser et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44
- (2011) B. Rosental et al. JOURNAL OF IMMUNOLOGY
- T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
- (2011) K Mihara et al. LEUKEMIA
- Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens
- (2011) Laurent Boissel et al. LEUKEMIA & LYMPHOMA
- IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
- (2011) Claudia Brehm et al. PLoS One
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Unifying concepts of MHC-dependent natural killer cell education
- (2011) Julie M. Elliott et al. TRENDS IN IMMUNOLOGY
- A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2
- (2010) S. Sivori et al. BLOOD
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
- (2010) L. Moretta et al. BLOOD
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
- (2010) Tolga Sutlu et al. CYTOTHERAPY
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus
- (2010) Chul-Woo Pyo et al. PLoS One
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
- (2009) M. Nakayama et al. BLOOD
- Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma
- (2009) M Watanabe et al. BRITISH JOURNAL OF CANCER
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Anti-CD20 monoclonal antibodies: historical and future perspectives
- (2009) S. H. Lim et al. HAEMATOLOGICA
- Macrophage- and Dendritic-Cell-Derived Interleukin-15 Receptor Alpha Supports Homeostasis of Distinct CD8+ T Cell Subsets
- (2009) Erwan Mortier et al. IMMUNITY
- Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies
- (2009) Gadi Gazit Bornstein et al. INVESTIGATIONAL NEW DRUGS
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started